Joel H. Kaufman
Overview
Joel H. Kaufman received an average of $265K in total compensation, including $189K in salary, at Navidea Biopharmaceuticals from 2018 to 2021.
Source: SEC filings on October 24, 2022 and August 2, 2021.
Related executives
We found 17 more executives who work or worked at Navidea Biopharmaceuticals.
Michael Rosol
Navidea Biopharmaceuticals
Chief Medical Officer
Erika Eves
Navidea Biopharmaceuticals
Vice President, Finance & Administration
Jed Latkin
Navidea Biopharmaceuticals
Chief Executive Officer
Michel Mikhail
Navidea Biopharmaceuticals
Chief Regulatory Officer
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
Thomas Klima
Navidea Biopharmaceuticals
Senior Vice President and Chief Commercial Officer
William Regan
Navidea Biopharmaceuticals
Senior Vice President and Chief Compliance Officer
News
Navidea Biopharmaceuticals CEO Jed Latkin's 2021 pay rises 10% to $1.3M
October 24, 2022
Navidea Biopharmaceuticals CEO Jed Latkin's 2020 pay jumps 66% to $1.2M
August 2, 2021
Navidea Biopharmaceuticals CEO Jed Latkin's 2019 pay rises 16% to $740K
July 31, 2020
Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
June 28, 2019